These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1333055)

  • 1. 3',5'-cyclic adenosine monophosphate-regulated enhancer binding (CREB) activity is required for normal growth and differentiated phenotype in the FRTL5 thyroid follicular cell line.
    Woloshin PI; Walton KM; Rehfuss RP; Goodman RH; Cone RD
    Mol Endocrinol; 1992 Oct; 6(10):1725-33. PubMed ID: 1333055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone receptors and 3,5,3'-triiodothyronine biological effects in FRTL5 thyroid follicular cells.
    Akiguchi I; Strauss K; Borges M; Silva JE; Moses AC
    Endocrinology; 1992 Sep; 131(3):1279-87. PubMed ID: 1324156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent and interactive effects of tetradecanoyl phorbol acetate on growth and differentiated functions of FRTL5 cells.
    Lombardi A; Veneziani BM; Tramontano D; Ingbar SH
    Endocrinology; 1988 Sep; 123(3):1544-52. PubMed ID: 2841099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of signal transduction pathways in FRTL5 thyroid follicular cells: studies with stable expression of beta 2-adrenergic receptors.
    Tsuzaki S; Cone RD; Frazier AL; Moses AC
    Endocrinology; 1991 Mar; 128(3):1359-68. PubMed ID: 1847855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dominant negative CREB (cAMP response element-binding protein) isoform inhibits thyrocyte growth, thyroid-specific gene expression, differentiation, and function.
    Nguyen LQ; Kopp P; Martinson F; Stanfield K; Roth SI; Jameson JL
    Mol Endocrinol; 2000 Sep; 14(9):1448-61. PubMed ID: 10976922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo.
    Walton KM; Rehfuss RP; Chrivia JC; Lochner JE; Goodman RH
    Mol Endocrinol; 1992 Apr; 6(4):647-55. PubMed ID: 1350057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rat gamma- and non-gamma-interferons on the expression of Ia antigen, growth, and differentiated functions of FRTL5 cells.
    Misaki T; Tramontano D; Ingbar SH
    Endocrinology; 1988 Dec; 123(6):2849-57. PubMed ID: 2461853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter.
    Ikuyama S; Shimura H; Hoeffler JP; Kohn LD
    Mol Endocrinol; 1992 Oct; 6(10):1701-15. PubMed ID: 1333054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cells.
    Tsuzaki S; Moses AC
    Endocrinology; 1990 Jun; 126(6):3131-8. PubMed ID: 1972059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of acute and chronic exposure to interferon-gamma on cyclic adenosine 3',5'-monophosphate response element-regulated gene expression.
    Saavedra AP; Cass LA; Prendergast GV; Meinkoth JL
    Endocrinology; 2000 Feb; 141(2):606-14. PubMed ID: 10650941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/enhancer-binding protein-homologous protein expression and transcriptional activity are regulated by 3',5'-cyclic adenosine monophosphate in thyroid cells.
    Pomerance M; Carapau D; Chantoux F; Mockey M; Correze C; Francon J; Blondeau JP
    Mol Endocrinol; 2003 Nov; 17(11):2283-94. PubMed ID: 12907753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-independent mutant clones from FRTL5 rat thyroid cells: hormonal control mechanisms in differentiated cells.
    Tramontano D; Rotella CM; Toccafondi R; Ambesi-Impiombato FS
    Endocrinology; 1986 Feb; 118(2):862-8. PubMed ID: 3002769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydrocortisone on the ability of thyrotropin to increase deoxyribonucleic acid synthesis and iodide uptake in FRTL-5 rat thyroid cells: opposite regulation of adenosine 3',5'-monophosphate signal action.
    Saji M; Kohn LD
    Endocrinology; 1990 Oct; 127(4):1867-76. PubMed ID: 2169405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism.
    Damante G; Chazenbalk G; Russo D; Rapoport B; Foti D; Filetti S
    Endocrinology; 1989 Jun; 124(6):2889-94. PubMed ID: 2542003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine has divergent effects on deoxyribonucleic acid synthesis in FRTL5 cells: inhibition of thyrotropin-stimulated and potentiation of insulin-like growth factor-I-stimulated thymidine incorporation.
    Moses AC; Tramontano D; Veneziani BM; Frauman AG
    Endocrinology; 1989 Nov; 125(5):2758-65. PubMed ID: 2477235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase.
    Tortora G; Pepe S; Cirafici AM; Ciardiello F; Porcellini A; Clair T; Colletta G; Cho-Chung YS; Bianco AR
    Cell Growth Differ; 1993 May; 4(5):359-65. PubMed ID: 8518230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cyclic AMP response element binding protein in transactivation of scavenger receptor class B type I promoter in transfected cells and in primary cultures of rat theca-interstitial cells.
    Towns R; Menon KM
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):23-30. PubMed ID: 16298471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
    Aucoin R; Reiland J; Roy M; Marchetti D
    J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of cAMP-response-element-binding protein ('CREB') induces apoptosis.
    Saeki K; Yuo A; Suzuki E; Yazaki Y; Takaku F
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):249-55. PubMed ID: 10493936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.